CLIN.L Share News (CLIN)

CLIN.L Information

There is currently no data for CLIN

UK Earnings, Trading Statements Calendar - Next 7 Days

Tue, 16th Feb 2021 15:58

Wednesday 17 February
British American Tobacco PLC	Full Year Results
Burford Capital Ltd	Trading Statement
Gattaca PLC	Trading Statement
Hochschild Mining PLC	Full Year Results
Plus500 Ltd	Full Year Results
Rio Tinto PLC	Full Year Results
Transense Technologies PLC	Half Year Results
Thursday 18 February
Arbuthnot Banking Group PLC	Trading Statement
Barclays PLC	Full Year Results
Hays PLC	Half Year Results
Hochschild Mining PLC	Full Year Results
Indivior PLC	Full Year Results
Moneysupermarket.com Group PLC	Full Year Results
Primary Health Properties PLC	Full Year Results
Smith & Nephew PLC	Full Year Results
South32 Ltd	Half Year Results
Trifast PLC	Trading Statement
Wilmington PLC	Half Year Results
Friday 19 February
Kingspan Group PLC	Full Year Results
NatWest Group PLC	Full Year Results
SEGRO PLC	Full Year Results
TBC Bank Group PLC	Full Year Results
Monday 22 February
Associated British Foods PLC	Trading Statement
Benchmark Holdings PLC	Q1 Results
Dechra Pharmaceuticals PLC	Half Year Results
Finsbury Food Group PLC	Half Year Results
Fonix Mobile PLC	Half Year Results
Kosmos Energy Ltd	Q4 Results
President Energy PLC	Trading Statement
Sylvania Platinum Ltd	Half Year Results
Tristel PLC	Half Year Results
Tuesday 23 February
Diurnal Group PLC	Half Year Results
McBride PLC	Half Year Results
Clinigen Group PLC	Half Year Results
Springfield Properties PLC	Half Year Results
HSBC Holdings PLC	Full Year Results
InterContinental Hotels Group PLC	Full Year Results
Conduit Holdings Ltd	Full Year Results

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

14 Jul 2020 09:07

Clinigen FY revenues continue to rise, profit growth slowed by Covid-19

(Sharecast News) - Pharmaceutical group Clinigen warned full-year profit growth would be at the lower end of guidance as a result of the Covid-19 pandemic and the launch of a low-cost competitor to its Foscavir drug.

13 Jul 2020 16:29

Clinigen gets orphan drug designation for 'aldesleukin' in the US

(Sharecast News) - Pharmaceutical services company Clinigen Group announced on Monday that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted orphan drug designation for 'aldesleukin', in the treatment of amyotrophic lateral sclerosis (ALS).

13 Jul 2020 13:48

Monday broker round-up

(Sharecast News) - Kingfisher: RBC Capital Markets reiterates outperform with a target price of 275.0p

13 Jul 2020 08:41

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

14 Jun 2020 19:22

Sunday newspaper round-up: Two meters, Rolls Royce, Clinigen

(Sharecast News) - Senior scientists have reported flaws in an influential World Health Organization-commissioned study into the risks of coronavirus infection and say it should not be used as evidence for relaxing the UK's 2-metre physical distancing rule. Critics of the distancing advice, which states that people should keep at least 2 metres apart, believe it is too cautious. They seized on the research commissioned by the WHO, which suggested a reduction from 2 metres to 1 would raise infection risk only marginally, from 1.3% to 2.6%. - Guardian

28 May 2020 13:34